Compare BioNTech SE - ADR (BNTX) vs AT&T Inc. (T) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs AT&T Inc. — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while AT&T Inc. trades at $24.4 (market cap $167.88B). The key difference: AT&T Inc. is far larger — about 7.2× BioNTech SE - ADR's market cap, and AT&T Inc. pays a 4.53% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | T | |
|---|---|---|
Market Cap | $23.31B | $167.88B |
Sector | Health | Media |
52-Week High | $119.34 | $29.62 |
52-Week Low | $83.89 | $20.49 |
Enterprise Value | $6.60B | $313.20B |
Dividend Yield | — | 4.53% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About AT&T Inc.
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →
